OncoDaily Grand Rounds at ASCO 2026: Sarcoma Edition

Why Treating Cancer Is Not Enough? The Missing Piece in Oncology Care: Interview with Dr. Konstantina Boniou

The Throne Has Changed Hands: T-DXd Displaces T-DM1 in Post-Neoadjuvant HER2+ Breast Cancer

A Team at the Champalimaud Clinical Centre Performed the First Robotic Mastectomy in Portugal

Alessandro Hammond: Cancer Researcher Used His Own App to Save His Life

Oncology News, Insights, Stories by OncoDaily

Myelo 2026
OncoDaily

Myelo 2026: Virtual Global Congress on Multiple Myeloma

AYA - OncoDaily
Not To Miss

20 Posts Not To Miss From AYA Cancer Awareness Week 2026

How I Treat Head and Neck Cancers
OncoDaily

How I Treat Head and Neck Cancers in 2026: OncoDaily Virtual Summit

Tom Powles: Breaking Down 4 Global Phase III ADC Trials in Urothelial Cancer

Top 10 OncoGrants: Global Fellowships, Translational Funding & International Research Awards — April 2026

Oncology Biotech Updates This Week: Gilead's $5B ADC Acquisition, Tarlatamab's China Approval, and Why Biology Remains Biotech's True Bottleneck

What Dogs Teach Us About Brain Tumors: The Untapped Power of Comparative Oncology

ctDNA Blood Tests in Colorectal Cancer Screening: High Specificity, Limited Detection of Precancerous Lesions

Bridging the Gap: Sustainable Cancer Care in Low and Middle Income Countries

Gilead Seizes Next-Generation ADC Powerhouse Tubulis in Landmark $5 Billion Oncology Acquisition

Voices
Bhavin Vadodariya

Bhavin Vadodariya: When an Incidental Diagnosis Becomes an Oncological Dilemma

Matt Scheff: Grateful for an Inspiring Visit to St. Jude Children’s Research Hospital

Stacie Lindsey: Honored to Attend Cholangiocarcinoma Foundation Symposium at Mass General Hospital

George Kumar: The Cancer Gap America Isn’t Talking About - Where You Live Determines Whether You Benefit

Child Marriage Raises Risks of Violence, Poor Health, and Lost Education - WHO

Margaret Gatti-Mays: Supporting Cancer Researchers at Ohio State Through Pelotonia

GC-OS Abstract Submissions are Now Open - International Cardio-Oncology Society

FDA Approvals
Tecartus

FDA Grants Full Approval of Tecartus for Relapsed/Refractory Mantle Cell Lymphoma in Adults

FDA Grants Fast Track Designation to TRI-611 in ALK-Positive NSCLC

Aktis Advances Radiopharmaceutical Pipeline With AKY-2519 FDA Clearance

FDA Grants Full Approval of BRAFTOVI Combination Regimen in 1L Metastatic Colorectal Cancer

FDA Approves Combination Treatment of VENCLEXTA (venetoclax) and Acalabrutinib for Previously Untreated Patients With CLL

Monthly RYBREVANT FASPRO (Amivantamab) Approved by FDA for EGFR-Mutated NSCLC

PANOVA-3 Leads to FDA Approval of Optune Pax in Locally Advanced Pancreatic Cancer

OncoDaily 100
100 Xfluencers in Prostate Cancer

100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2025

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Top 100 Xfluencers in Breast Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Celebrities and Cancer

OncoCalendar

Leukemia in the US Hispanic Population: Room for Improvement - Resonance

Resonance

17 Apr
Leukemia

Myelo 2026: Virtual Global Congress on Multiple Myeloma

OncoDaily

23 Apr
Multiple Myeloma

How I Treat Head and Neck Cancers in 2026: OncoDaily Virtual Summit

OncoDaily

30 Apr
Head and Neck Cancers

Scalp Cooling for Prevention of Hair Loss in Pediatric ALL - Resonance

Resonance

08 May
Scalp Cooling

Treatment Strategy for a 4-Year-Old Boy with Newly Diagnosed MLL-AF4-Positive B-ALL

Resonance

24 Apr
Resonance

Immune-oncology
10 Must-Read Posts in Immuno-Oncology This Week

10 Must-Read Posts in Immuno-Oncology This Week

The Myth of Lifelong Immunotherapy: Is It Safe to Stop Treatment After Response?

10 Must-Read Posts in Immuno-Oncology This Week

Positive Topline Results from Phase 3 RINGSIDE Trial: Varegacestat Significantly Improves Outcomes in Desmoid Tumors

How Do Pharmacists Protect the Safety and Effectiveness of Immunotherapy?

10 Must-Read Posts in Immuno-Oncology This Week

10 Must-Read Posts in Immuno-Oncology This Week

Gastrointestinal-Oncology
crDNA for colorectal cancer

ctDNA Blood Tests in Colorectal Cancer Screening: High Specificity, Limited Detection of Precancerous Lesions

French Intergroup Guidelines 2026: Updates on Gastric Cancer Management

Top 10 Gastroesophageal Cancer Updates – March 2026

10 Must-Read Posts In GI Oncology This Week

EMERALD-3 Trial: Durvalumab and Tremelimumab Plus Lenvatinib and TACE in HCC

Phase 3 BATTMAN Trial Launches BOT/BAL in MSS or pMMR Metastatic Colorectal Cancer

Phase 3 ATOMIC trial Updates: Atezolizumab plus FOLFOX for Stage III dMMR Colon Cancer

Breast-Oncology
T-DXd

The Throne Has Changed Hands: T-DXd Displaces T-DM1 in Post-Neoadjuvant HER2+ Breast Cancer

Breast-Conserving Surgery Plus Radiation Did Not Worsen Survival in Young BRCA1/2 Carriers, but Second Breast Events Remained Higher

Complementary and Alternative Medicine in Breast Cancer: NCDB Study Links CAM Use to Worse Survival

Signatera ctDNA in Older Women with ER+ Breast Cancer: A New Path Toward Surgical De-Escalation

Early Luminal Breast Cancer: A 2026 Practical Guide to Systemic Therapy Based on the Trials That Changed Practice

Datopotamab Deruxtecan Improves PFS and OS in First-Line Advanced TNBC in TROPION-Breast02

HER2 Heterogeneity in Breast Cancer May Explain Why Some Tumors Escape T-DXd

Lung-Oncology
TTF-1 Negativity in Lung Adenocarcinoma May Signal Broader Treatment Resistance

TTF-1 Negativity in Lung Adenocarcinoma May Signal Broader Treatment Resistance

Serum CEA May Reflect Tumor Biology Across Molecular Subtypes in Metastatic NSCLC

KRAS G12C NSCLC: Promising Strategy as Cetuximab Boosts KRAS Inhibitor Response

Definitive Radiotherapy to the Primary Tumor in Stage IV NSCLC: What the New IASLC Consensus Means

Is Pathologic Complete Response a Reliable Surrogate Endpoint for Survival After Neoadjuvant Immunotherapy in Resectable NSCLC?

2 New ES-SCLC Treatments Backed by EMA: A Major Shift in Care

3 Clinically Important Lessons From Sequential Targeting in EGFR-Mutant NSCLC

OncoDaily TV
Bridging the Gap: Sustainable Cancer Care in Low and Middle Income Countries

Bridging the Gap: Sustainable Cancer Care in Low and Middle Income Countries

Ensuring equitable access to cancer care worldwide

Ensuring equitable access to cancer care worldwide: Pat Garcia-Gonzalez

How to Publish High-Impact Research in Top Journals

How to Publish High-Impact Research in Top Journals: Gustavo Monnerat

Empowering Oncologists

Empowering Oncologists: How Social Media Can Lead To Professional Collabortions And Advancement?

Dr. Amar Rewari

Challenges in Modern Cancer Care And How to Address Them: Dr. Amar Rewari

Fight Cancer, City of hope

This Could Change How We Fight Cancer Forever: Dr. Charles M. Balch

Ricardo Marques

The Moment People Ask for Help Is the Moment We Can’t Miss: Ricardo Marques

vraniCURE Nicole Beck Clifford

Building a Future Without Breast Cancer: vraniCURE & MBCure

Life is More Than Myeloma: Beyond Survival to Quality of Life

Life is More Than Myeloma: Beyond Survival to Quality of Life

OncoGrants

OncoGrants Now on LinkedIn: Weekly Funding Opportunities Delivered to Your Professional Feed

oncoffee

ONCOFFEE: Ricky Frazer – Immunotherapy, Leadership, and Patient-Centered Care

Science And Spirituality: Rethinking Healing in Modern Medicine: Dr. Anna Yusim

Science And Spirituality: Rethinking Healing in Modern Medicine: Dr. Anna Yusim

Not To Miss
OncoGrants

Top 10 OncoGrants: Global Fellowships, Translational Funding & International Research Awards — April 2026

20 Posts Not To Miss From AYA Cancer Awareness Week 2026

10 Posts From Lung Oncology You Can’t Miss This Week

15 Posts Not To Miss From World Health Day - April 7

100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2025

Top 10 OncoGrants This Week: Early-Career Awards, EU Cancer Mission Calls, and Funding Research

Who Are the 2026 Healthcare Businesswomen’s Association Rising Stars and Luminaries?

OncoGrants
Cancer Research UK–Funded International Accelerator Award 2026

Cancer Research UK–Funded International Accelerator Award 2026

IARC Visiting Scientist Fellowship Programme 2026 (WHO / France)

IARC Visiting Scientist Fellowship Programme 2026 (WHO / France)

Cancer Council Victoria Grants in Aid 2026

Cancer Council Victoria Grants in Aid 2026

AREF Research Development Fellowship 2026/27 (Africa)

AREF Research Development Fellowship 2026/27 (Africa)

KWF PIPELINE Call 2026 — Dutch Cancer Society (Netherlands/Europe)

KWF PIPELINE Call 2026 — Dutch Cancer Society (Netherlands/Europe)

UICC Bourse pour l’Afrique Francophone 2026

UICC Bourse pour l’Afrique Francophone 2026

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Colorectal Cancer

Colorectal Cancer: Epidemiology, Pathogenesis, Diagnosis, and Therapeutic Advances

Cholangiocarcinoma: Latest Risk Factors, Symptoms, Diagnosis, and 2025 Advanced Treatment Options for Bile Duct Cancer

Pheochromocytoma: Causes, Diagnosis, Treatment, and Breakthrough 2025 Advances in Management

Cervical Cancer: Symptoms, Causes, Stages, Diagnosis and Treatment

Craniopharyngioma: Symptoms, Diagnosis, Treatment, and 2025 Breakthroughs in Targeted Therapy and Precision Care

Malignant Schwannoma: Comprehensive Guide to Causes, Symptoms, Diagnosis, Treatment, Prognosis, and 2025 Advances in Schwannoma Care

Meningioma: Types, Symptoms, Diagnosis, Treatment, Malignancy Risk, and 2025 Breakthroughs

CancerWorld

Oncologists
Karima Oualla

Karima Oualla

Oncologists Location Fès, Morocco
Francesco Massari

Francesco Massari

Oncologists Location Bologna, Italy
Elie Dib

Elie G. Dib

Oncologists Location Baltimore, USA
Ruzanna Papyan

Ruzanna Papyan

Oncologists Location Yerevan, Armenia
Claudio Cerchione

Claudio Cerchione

Oncologists Location Bologna, Italy
Jan Fagerberg

Jan Fagerberg

Oncologists Location Paris, France
Justin Nathaniel Baker

Justin Nathaniel Baker

Oncologists Location Stanford, USA
Michel Ducreux

Michel Ducreux

Oncologists Location Villejuif, France

Oncology Drugs
Sacituzumab Tirumotecan

Sacituzumab Tirumotecan: What Patients Should Know About This Emerging Cancer Treatment

Sacituzumab Tirumotecan: Clinical Development, Mechanism, and Emerging Role in Modern Oncology

Lurbinectedin: What Patients Should Know

Lurbinectedin in Oncology: Mechanism, Clinical Data, Evolving Role, and Future Directions

Bemarituzumab: What Patients with Gastric Cancer Should Know

Bemarituzumab: Uses in Cancer, Side Effects, Dosages, Expectations and More

GSK5764227 (HS-20093): A Novel B7-H3 Targeted Antibody–Drug Conjugate Under Clinical Investigation

OncoDaily Magazine

New Paper Alert
KRAS G12V

KRAS G12V–Mutated NSCLC: Smoking-Driven Biology and Immunotherapy Sensitivity

KEYNOTE-158

KEYNOTE-158 Trial: Pembrolizumab Monotherapy in MSI-H/dMMR Recurrent Gliomas:

PRINCE Trial

PRINCE Trial: Lu-PSMA-617 Plus Pembrolizumab in Metastatic Castration-Resistant Prostate Cancer

NCCN 2026

NCCN Annual Conference 2026: The Evolving Treatment Landscape for Gastric, Esophageal, and EGJ Cancers

TORPEdO Trial

TORPEdO Trial Evaluates Safer Radiotherapy for Oropharyngeal Cancer

Thymic Health And Immunotherapy Outcomes In Patients With Cancer

Thymic Health And Immunotherapy Outcomes In Patients With Cancer

OncoDaily Medical Journal

Oncology Nursing

10.69690/ODMJ-001-0404-7332

Enhancing Palliative Care Through Simulation-Based Workshops for Effective Symptom Management
Original Research

Pediatric Oncology

10.69690/ODMJ-001-0310-6131

Prevalence and Associated Factors of Cholelithiasis in Pediatric Sickle Cell Disease Patients at Qatif Health Network, Saudi Arabia
Original Research

Precision Oncology

10.69690/ODMJ-002-0226-7267

Unlocking Precision Medicine in Multiple Myeloma: Venetoclax and Novel Targeted Therapies
Review

Oncology Nursing

10.69690/ODMJ-002-0204-6423

Extracorporeal membrane oxygenation in the management of oncologic critical illness
Review

Radiation Oncology

10.69690/ODMJ-018-3101-6699

Comparative Evaluation of DIR-Based Auto-Adaptive, Manual, and Semi-Automated Contouring for Pelvic OARs in Cervical Cancer Adaptive Radiotherapy
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-6997

Validity of 18F FDG-PET/CT in the Detection of Bone Marrow Disease in Hodgkin's and Non-Hodgkin's Lymphoma
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-7103

Dosimetric Comparison of 5-, 7-, and 9-Field SIB-IMRT Plans in Prostate Cancer Using 100% Isodose-Based Target Evaluation
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-6652

Radiation‐induced Lung Toxicity: A Crucial Problem in Thoracic Radiotherapy
Abstracts